CanSense
Karen W. has an extensive background in project management and biochemistry, with experience in various roles such as Chief Operating Officer, Director of Project Management, and Head of Project Delivery at companies like CanSense, PCI Pharma Services, and Axol Bioscience Ltd. Karen holds a PhD in Biochemistry from Swansea University, an MPhil in Biochemistry from University of Wales, Cardiff, and a BSc in Biochemistry from Royal Holloway, University of London.
This person is not in any teams
CanSense
CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.